High Impact Factor : 7.883
Submit your paper here

Impact Factor

7.883


Call For Paper

Volume 10 Issue 12 December 2024


Download Paper Format


Copyright Form


Share on

EFFECT OF COVISHIELD

  • Author(s):

    Sandip D Pagare | Andhale A.K | Kamble H.V.

  • Keywords:

    Covishield, Vaccine Effectiveness, Test-negative Design

  • Abstract:

    Covishield (ChAdOx1-nCOV Or AZD1222) Is A Recombinant, Replication-deficient Chimpanzee Adenovirus Vector Encoding The SARS-CoV-2 S Glycoprotein Vaccine Currently Being Developed By The Serum Institute Of India (SII), Pune, Based On The AstraZeneca-Oxford

Other Details

  • Paper id:

    IJSARTV8I1156971

  • Published in:

    Volume: 8 Issue: 11 November 2022

  • Publication Date:

    2022-11-23


Download Article